Indication
Post-transplant Lymphoproliferative Disease
1 clinical trial
1 product
Clinical trial
Epstein-Barr Virus (EBV) -Specific T Memory Stem Cell (Tscm) Therapy to Treat EBV- Driven Lymphomas/ DiseasesStatus: Not yet recruiting, Estimated PCD: 2025-12-01